Clinical Usefulness of T-SPOT.TB Test for the Diagnosis of Tuberculosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Tuberculosis-specific ELISPOT assay (T-SPOT.TB, Oxford Immunotec, UK) is a test that detects interferon-gamma producing T-cells after stimulating patient’s lymphocytes with two kinds of tuberculosis-specific antigens (ESAT-6 and CFP-10). We evaluated clinical usefulness of T-SPOT.TB test in Korean adults with intermediate burden of tuberculosis and high rate of BCG vaccination at birth. Methods : T-SPOT.TB test was performed in 79 patients and 64 healthy volunteers and these patients and volunteers were classified into four groups: group 1, patients with active tuberculosis (n=30); group 2, patients with not-active tuberculosis (n=27); group 3, patients without tuberculosis (n=24); group 4, healthy volunteers without tuberculosis history (n=62). Positive rates and average spot counts of T-SPOT.TB test were obtained among these groups. Results : Positive rates of group 1 (96.4%) and group 2 (92.3%) were higher than those of group 3 (31.6%) and group 4 (27.4%) (P<0.0001). The sensitivity deduced from group 1 and specificity deduced from group 4 of T-SPOT.TB test were 96.4% and 72.6%, respectively. The average spot counts of group 1 and 2 were higher than those of group 3 and 4 (P<0.001). There was a tendency of increasing positive rate with increasing age. Overall agreement between T-SPOT.TB test and tuberculin skin test was 63.8% (kappa=0.29). Conclusions : T-SPOT.TB test would be a very useful screening and supplementary test for diagnosis of tuberculosis due to its high sensitivity. However, positive results of T-SPOT.TB should be cautiously interpreted because of high positivity in treated tuberculosis patients and healthy volunteers in Korea. (Korean J Lab Med 2010;30:171-7)
Abstract
Background : Tuberculosis-specific ELISPOT assay (T-SPOT.TB, Oxford Immunotec, UK) is a test that detects interferon-gamma producing T-cells after stimulating patient’s lymphocytes with two kinds of tuberculosis-specific antigens (ESAT-6 and CFP-10). We evaluated clinical usefulness of T-SPOT.TB test in Korean adults with intermediate burden of tuberculosis and high rate of BCG vaccination at birth. Methods : T-SPOT.TB test was performed in 79 patients and 64 healthy volunteers and these patients and volunteers were classified into four groups: group 1, patients with active tuberculosis (n=30); group 2, patients with not-active tuberculosis (n=27); group 3, patients without tuberculosis (n=24); group 4, healthy volunteers without tuberculosis history (n=62). Positive rates and average spot counts of T-SPOT.TB test were obtained among these groups. Results : Positive rates of group 1 (96.4%) and group 2 (92.3%) were higher than those of group 3 (31.6%) and group 4 (27.4%) (P<0.0001). The sensitivity deduced from group 1 and specificity deduced from group 4 of T-SPOT.TB test were 96.4% and 72.6%, respectively. The average spot counts of group 1 and 2 were higher than those of group 3 and 4 (P<0.001). There was a tendency of increasing positive rate with increasing age. Overall agreement between T-SPOT.TB test and tuberculin skin test was 63.8% (kappa=0.29). Conclusions : T-SPOT.TB test would be a very useful screening and supplementary test for diagnosis of tuberculosis due to its high sensitivity. However, positive results of T-SPOT.TB should be cautiously interpreted because of high positivity in treated tuberculosis patients and healthy volunteers in Korea. (Korean J Lab Med 2010;30:171-7)
참고문헌 (11)
- 이정연, "체외 Interferon-gamma 검사를 이용한 결핵감염의 진단", Tuberculosis and Respiratory Diseases, 60(5), pp.497~509 (2006), 대한결핵및호흡기학회
- Lee JY, "Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection", Eur Respir J, 28, pp.24~30 (2006)
- Domínguez J, "T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment", Diagn Microbiol Infect Dis, 63, pp.43~51 (2009)
- Dye C, "Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project", JAMA, 282, pp.677~686 (1999)
- "Tuberculosis"[URL]
- Kang YA, "Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country", JAMA, 293, pp.2756~2761 (2005)
- Kang YA, "Usefulness of whole-blood interferon-g assay and interferon-g enzymelinked immunospot assay in the diagnosis of active pulmonary tuberculosis", Chest, 132, pp.959~965 (2007)
- American Thoracic Society, "Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999", Am J Respir Crit Care Med, 161, pp.1376~1395 (2000)
- Clinical and Laboratory Standards Institute, "User protocol for evaluation of qualitative test performance; Approved guideline-Second edition. CLSI document EP12-A2" (2008), Clinical and Laboratory Standards Institute
- Linnet K, "Selection and analytical evaluation of methods-with statistical technique in Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed", pp.367~368 (2006), Elsevier Saunders
- Provinciali M, "Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly", Gerontology, 55, pp.314~321 (2009)